THE Society of Hospital Pharmacists of Australia (SHPA)has boosted the size of its Board of Directors, with the addition of David Brennan, David Butt and Lindsay Cane as new "expert appointments".
The positions were enabled by overwhelming member support last year of the new, contemporary SHPA constitution (PD 26 Sep 2017).
Professor Michael Dooley, who was re-elected as SHPA president in Dec, said the new board would bring broad strategic experience and expertise at a time of strong organisational growth and a rapidly evolving pharmacy landscape.
"Not only is membership reaching new heights, but our growing suite of complementary member-driven programs is ensuring SHPA is the essential professional partner of pharmacists and technicians committed to making a difference in the challenging and complex hospital setting," Dooley said.
Brennan is an experienced investment banking executive and company director, while Lindsay Cane is currently ceo of the Royal Far West which provides specialist medical care and allied health support services for children in remote NSW.
David Butt is a highly experienced health executive with his career including time as Federal Health Department deputy secretary - more on the board at shpa.org.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 11 May 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 May 18